Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Top-line data from the double-blind, U.S. Phase IIb/III S.E.A.T.T.L.E. trial in 508 patients with GA secondary to dry age-related AMD showed that once-daily 2.5, 5 and 10 mg oral emixustat each missed...